help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Authier, F.
Right arrow Articles by De Galle, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Authier, F.
Right arrow Articles by De Galle, B.

Endocrinology, Vol 131, 447-457, Copyright © 1992 by Endocrine Society


ARTICLES

Ligand-mediated internalization of glucagon receptors in intact rat liver

F Authier, B Desbuquois and B De Galle
INSERM U.30, Hopital des Enfants-Malades, Paris, France.

The ligand-induced internalization of the hepatic glucagon receptor has been studied in rats in vivo using cell fractionation. Injection of glucagon (11 nmol/100 g BW) led to a 2- to 3-fold increase in glucagon- binding activity in Golgi-endosomal (GE) fractions along with a 10-20% decrease in binding activity in plasma membrane (PM) fractions. These changes were time and dose dependent, reaching a maximum by 12-24 min and undergoing reversal in 2 h. Glucagon injection also caused a 20% decrease in glucagon binding to the total particulate fraction, which did not occur when binding was measured in the presence of the detergent octylglucoside. The change in glucagon-binding activity in PM and GE fractions resulted mainly from a change in receptor number; affinity remained unaffected (apparent Kd, 0.5 and 5 nM, respectively). A 5- to 10-fold increase in the glucagon content of GE fractions was observed in glucagon-treated rats. Neither the distribution of PM and Golgi marker enzymes nor that of the asialoglycoprotein receptor was affected by glucagon treatment. Regardless of glucagon treatment, glucagon receptors in GE fractions were less sensitive to GTP than receptors in PM fractions with respect to both inhibition of steady state binding and dissociation of prebound ligand. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, glucagon-receptor complexes formed in PM and GE fractions and subsequently cross-linked showed the same apparent mol wt (57 kilodaltons). In addition, they were identically sensitive to N-glycanase treatment, with two major species of lower mol wt generated. However, only cross-linked complexes associated with PM fractions showed detectable GTP sensitivity. GE fractions displayed a GTP-sensitive adenylate cyclase activity that was about 12 times lower than that of PM fractions. In both fractions, activity was stimulated by the addition of forskolin (8-fold) and, to a lesser extent, glucagon (3-fold). In vivo glucagon treatment led to an increase in activity in GE, but not PM, fractions. These results are consistent with the view that upon acute occupancy, hepatic glucagon receptors are rapidly and specifically internalized along with their ligand. During this process, receptor retained structural integrity and uncouple, albeit partially, from other components of the adenylate cyclase system.


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Authier, P. H. Cameron, C. Merlen, M. Kouach, and G. Briand
Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(19-29)
Endocrinology, December 1, 2003; 144(12): 5353 - 5364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Authier, M. Metioui, S. Fabrega, M. Kouach, and G. Briand
Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D
J. Biol. Chem., March 8, 2002; 277(11): 9437 - 9446.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Authier, G. M. Danielsen, M. Kouach, G. Briand, and G. Chauvet
Identification of Insulin Domains Important for Binding to and Degradation by Endosomal Acidic Insulinase
Endocrinology, January 1, 2001; 142(1): 276 - 289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Legare, R. Drouin, M. Milot, D. Massicotte, F. Peronnet, G. Massicotte, and C. Lavoie
Increased density of glucagon receptors in liver from endurance-trained rats
Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E193 - E196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Authier, M. Metioui, A. W. Bell, and J. S. Mort
Negative Regulation of Epidermal Growth Factor Signaling by Selective Proteolytic Mechanisms in the Endosome Mediated by Cathepsin B
J. Biol. Chem., November 19, 1999; 274(47): 33723 - 33731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Authier, J. S. Mort, A. W. Bell, B. I. Posner, and J. J. M. Bergeron
Proteolysis of Glucagon within Hepatic Endosomes by Membrane-associated Cathepsins B and D
J. Biol. Chem., June 30, 1995; 270(26): 15798 - 15807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society